|
Re: Epigenetics and Coronavirus
|
7
|
Resverlogix Corp.
|
Mar 23, 2020 03:31PM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 05:10PM
|
|
Re: Embargo
|
3
|
Zenith Epigenetics
|
Mar 31, 2017 12:13PM
|
|
Re: EMA
|
3
|
Resverlogix Corp.
|
Jun 10, 2020 05:27PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 19, 2018 01:18PM
|
|
Re: Eligibility for registered accounts in Canada
|
3
|
Zenith Epigenetics
|
Aug 19, 2018 09:07PM
|
|
Re: eGFR and Cognition?
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 01:39AM
|
|
Re: eGFR and Cognition?
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 02:40AM
|
|
Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 10:20AM
|
|
Re: Eastern exercised some $0.90 cent warrants
|
3
|
Resverlogix Corp.
|
Aug 10, 2018 02:38AM
|
|
Re: Earliest minute/hour
|
5
|
Resverlogix Corp.
|
Sep 29, 2019 02:51PM
|
|
Re: Dunno if anyone saw that bid for rvx.wt.a for .40
|
4
|
Resverlogix Corp.
|
Oct 03, 2019 03:41PM
|
|
Re: DSMB 7th review??
|
2
|
Resverlogix Corp.
|
Jul 18, 2018 05:28PM
|
|
Re: DSMB 7th review??
|
4
|
Resverlogix Corp.
|
Jul 19, 2018 12:42AM
|
|
Re: DSMB 5 postitive recomendation
|
4
|
Resverlogix Corp.
|
Nov 01, 2017 10:56AM
|
|
Re: DSMB
|
4
|
Resverlogix Corp.
|
Feb 21, 2019 06:49PM
|
|
Re: DSMB
|
3
|
Resverlogix Corp.
|
Feb 21, 2019 08:44PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 25, 2022 03:15PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 25, 2022 06:45PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 27, 2022 01:58AM
|
